Promising Biomarkers in Renal Cell Carcinoma

Renal cell carcinoma (RCC) incidence has been increasing in recent years, and it now represents the sixth most common cancer diagnosis in men and the tenth in women. Although this is partly due to increased detection of incidental small renal masses on unrelated imaging, advanced RCC continues to be...

Full description

Saved in:
Bibliographic Details
Main Author: Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Société Internationale d’Urologie Journal
Subjects:
Online Access:https://siuj.org/index.php/siuj/article/view/92/16
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850254230401581056
author Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
author_facet Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
author_sort Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
collection DOAJ
description Renal cell carcinoma (RCC) incidence has been increasing in recent years, and it now represents the sixth most common cancer diagnosis in men and the tenth in women. Although this is partly due to increased detection of incidental small renal masses on unrelated imaging, advanced RCC continues to be diagnosed in a significant portion of patients, with more than 15% presenting with distant metastases. Biomarkers can be a cost-effective tool to identify high-risk patients and institute appropriate individualised therapies. While the literature in this field is nascent, this paper focuses on several biomarkers that have been extensively investigated in the diagnosis and prognosis of RCC, as well as in predicting its response to treatments, particularly the newer immuno-oncology drugs.
format Article
id doaj-art-6ceb9b245e2c43fa8ee7bc2d20782ade
institution OA Journals
issn 2563-6499
language English
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Société Internationale d’Urologie Journal
spelling doaj-art-6ceb9b245e2c43fa8ee7bc2d20782ade2025-08-20T01:57:11ZengMDPI AGSociété Internationale d’Urologie Journal2563-64992021-01-0121435210.48083/TNGM4076Promising Biomarkers in Renal Cell CarcinomaJada Kapoor, Francesco Claps, Carmen Mir, Joseph IschiaRenal cell carcinoma (RCC) incidence has been increasing in recent years, and it now represents the sixth most common cancer diagnosis in men and the tenth in women. Although this is partly due to increased detection of incidental small renal masses on unrelated imaging, advanced RCC continues to be diagnosed in a significant portion of patients, with more than 15% presenting with distant metastases. Biomarkers can be a cost-effective tool to identify high-risk patients and institute appropriate individualised therapies. While the literature in this field is nascent, this paper focuses on several biomarkers that have been extensively investigated in the diagnosis and prognosis of RCC, as well as in predicting its response to treatments, particularly the newer immuno-oncology drugs.https://siuj.org/index.php/siuj/article/view/92/16biomarkerskidney cancerdiagnosisprognosis
spellingShingle Jada Kapoor, Francesco Claps, Carmen Mir, Joseph Ischia
Promising Biomarkers in Renal Cell Carcinoma
Société Internationale d’Urologie Journal
biomarkers
kidney cancer
diagnosis
prognosis
title Promising Biomarkers in Renal Cell Carcinoma
title_full Promising Biomarkers in Renal Cell Carcinoma
title_fullStr Promising Biomarkers in Renal Cell Carcinoma
title_full_unstemmed Promising Biomarkers in Renal Cell Carcinoma
title_short Promising Biomarkers in Renal Cell Carcinoma
title_sort promising biomarkers in renal cell carcinoma
topic biomarkers
kidney cancer
diagnosis
prognosis
url https://siuj.org/index.php/siuj/article/view/92/16
work_keys_str_mv AT jadakapoorfrancescoclapscarmenmirjosephischia promisingbiomarkersinrenalcellcarcinoma